Dr Mitchel Alan Muhleman, MD - Medicare Nuclear Medicine in Ann Arbor, MI

Dr Mitchel Alan Muhleman, MD is a medicare enrolled "Nuclear Medicine" physician in Ann Arbor, Michigan. He graduated from medical school in 2011 and has 13 years of diverse experience with area of expertise as Nuclear Medicine. He is a member of the group practice Regents Of The University Of Michigan and his current practice location is 1500 E Medical Center Dr, Ann Arbor, Michigan. You can reach out to his office (for appointments etc.) via phone at (734) 936-4000.

Dr Mitchel Alan Muhleman is licensed to practice in Michigan (license number 4301508191) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1346598885.

Contact Information

Dr Mitchel Alan Muhleman, MD
1500 E Medical Center Dr,
Ann Arbor, MI 48109-5000
(734) 936-4000
Not Available



Physician's Profile

Full NameDr Mitchel Alan Muhleman
GenderMale
SpecialityNuclear Medicine
Experience13 Years
Location1500 E Medical Center Dr, Ann Arbor, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Mitchel Alan Muhleman graduated from medical school in 2011
  NPI Data:
  • NPI Number: 1346598885
  • Provider Enumeration Date: 08/15/2012
  • Last Update Date: 01/09/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0840418158
  • Enrollment ID: I20230120001324

Medical Identifiers

Medical identifiers for Dr Mitchel Alan Muhleman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346598885NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085N0904XRadiology - Nuclear Radiology 4301101020 (Michigan)Secondary
207U00000XNuclear Medicine 4301508191 (Michigan)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Michigan Health SystemAnn arbor, MIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Regents Of The University Of Michigan37794968562953

News Archive

Unintentional hot tub-related injuries increases by 160%, says study

Though hot tubs, whirlpools and spas are widely used for relaxation and fun, they can pose serious risk for injury. Over the past two decades, as recreational use of hot tubs has increased, so has the number of injuries. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1990-2007, the number of unintentional hot tub-related injuries increased by 160 percent, from approximately 2,500 to more than 6,600 injuries per year.

Student researchers get new view of the dynamics of cancer cells as they metastasize

A team of student researchers and their professors from 20 laboratories around the country have gotten a new view of cancer cells. The work could shed light on the transforming physical properties of these cells as they metastasize, said Jack R. Staunton, a Ph.D. candidate at Arizona State University in the lab of Prof. Robert Ros, and the lead author of a paper reporting on the topic.

Two scientists behind suit to block stem-cell research funding speak with lawmakers

The Wall Street Journal: "The two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said Wednesday they were motivated by ethical objections to destroying human embryos for medical research. The scientists, James Sherley of Boston and Theresa Deisher of Seattle, had never met until this week, when they flew to Washington to confer with House and Senate aides and lobby against research using embryonic stem cells.

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

World's first 3D heart printed using patient's own cells and biological materials

In a major medical breakthrough, Tel Aviv University researchers have "printed" the world's first 3D vascularised engineered heart using a patient's own cells and biological materials.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mitchel Alan Muhleman allows following entities to bill medicare on his behalf.
Entity NameRegents Of The University Of Michigan
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205868353
PECOS PAC ID: 3779496856
Enrollment ID: O20031106000325

News Archive

Unintentional hot tub-related injuries increases by 160%, says study

Though hot tubs, whirlpools and spas are widely used for relaxation and fun, they can pose serious risk for injury. Over the past two decades, as recreational use of hot tubs has increased, so has the number of injuries. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1990-2007, the number of unintentional hot tub-related injuries increased by 160 percent, from approximately 2,500 to more than 6,600 injuries per year.

Student researchers get new view of the dynamics of cancer cells as they metastasize

A team of student researchers and their professors from 20 laboratories around the country have gotten a new view of cancer cells. The work could shed light on the transforming physical properties of these cells as they metastasize, said Jack R. Staunton, a Ph.D. candidate at Arizona State University in the lab of Prof. Robert Ros, and the lead author of a paper reporting on the topic.

Two scientists behind suit to block stem-cell research funding speak with lawmakers

The Wall Street Journal: "The two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said Wednesday they were motivated by ethical objections to destroying human embryos for medical research. The scientists, James Sherley of Boston and Theresa Deisher of Seattle, had never met until this week, when they flew to Washington to confer with House and Senate aides and lobby against research using embryonic stem cells.

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

World's first 3D heart printed using patient's own cells and biological materials

In a major medical breakthrough, Tel Aviv University researchers have "printed" the world's first 3D vascularised engineered heart using a patient's own cells and biological materials.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mitchel Alan Muhleman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Mitchel Alan Muhleman, MD
3621 S State St,
Ann Arbor, MI 48108-1633

Ph: (734) 647-5299
Dr Mitchel Alan Muhleman, MD
1500 E Medical Center Dr,
Ann Arbor, MI 48109-5000

Ph: (734) 936-4000

News Archive

Unintentional hot tub-related injuries increases by 160%, says study

Though hot tubs, whirlpools and spas are widely used for relaxation and fun, they can pose serious risk for injury. Over the past two decades, as recreational use of hot tubs has increased, so has the number of injuries. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1990-2007, the number of unintentional hot tub-related injuries increased by 160 percent, from approximately 2,500 to more than 6,600 injuries per year.

Student researchers get new view of the dynamics of cancer cells as they metastasize

A team of student researchers and their professors from 20 laboratories around the country have gotten a new view of cancer cells. The work could shed light on the transforming physical properties of these cells as they metastasize, said Jack R. Staunton, a Ph.D. candidate at Arizona State University in the lab of Prof. Robert Ros, and the lead author of a paper reporting on the topic.

Two scientists behind suit to block stem-cell research funding speak with lawmakers

The Wall Street Journal: "The two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said Wednesday they were motivated by ethical objections to destroying human embryos for medical research. The scientists, James Sherley of Boston and Theresa Deisher of Seattle, had never met until this week, when they flew to Washington to confer with House and Senate aides and lobby against research using embryonic stem cells.

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

World's first 3D heart printed using patient's own cells and biological materials

In a major medical breakthrough, Tel Aviv University researchers have "printed" the world's first 3D vascularised engineered heart using a patient's own cells and biological materials.

Read more News

› Verified 9 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.